1. Home
  2. IRWD vs FLL Comparison

IRWD vs FLL Comparison

Compare IRWD & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • FLL
  • Stock Information
  • Founded
  • IRWD 1998
  • FLL 1987
  • Country
  • IRWD United States
  • FLL United States
  • Employees
  • IRWD N/A
  • FLL N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • FLL Hotels/Resorts
  • Sector
  • IRWD Health Care
  • FLL Consumer Discretionary
  • Exchange
  • IRWD Nasdaq
  • FLL Nasdaq
  • Market Cap
  • IRWD 111.2M
  • FLL 133.3M
  • IPO Year
  • IRWD 2010
  • FLL 1993
  • Fundamental
  • Price
  • IRWD $1.13
  • FLL $3.33
  • Analyst Decision
  • IRWD Buy
  • FLL Buy
  • Analyst Count
  • IRWD 5
  • FLL 5
  • Target Price
  • IRWD $4.94
  • FLL $5.80
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • FLL 150.5K
  • Earning Date
  • IRWD 11-06-2025
  • FLL 11-05-2025
  • Dividend Yield
  • IRWD N/A
  • FLL N/A
  • EPS Growth
  • IRWD N/A
  • FLL N/A
  • EPS
  • IRWD N/A
  • FLL N/A
  • Revenue
  • IRWD $308,519,000.00
  • FLL $297,653,000.00
  • Revenue This Year
  • IRWD N/A
  • FLL $4.96
  • Revenue Next Year
  • IRWD N/A
  • FLL $8.15
  • P/E Ratio
  • IRWD N/A
  • FLL N/A
  • Revenue Growth
  • IRWD N/A
  • FLL 8.24
  • 52 Week Low
  • IRWD $0.53
  • FLL $2.86
  • 52 Week High
  • IRWD $5.13
  • FLL $5.59
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 52.75
  • FLL 32.37
  • Support Level
  • IRWD $1.01
  • FLL $3.47
  • Resistance Level
  • IRWD $1.35
  • FLL $3.84
  • Average True Range (ATR)
  • IRWD 0.10
  • FLL 0.17
  • MACD
  • IRWD -0.02
  • FLL -0.01
  • Stochastic Oscillator
  • IRWD 33.33
  • FLL 7.14

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About FLL Full House Resorts Inc.

Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.

Share on Social Networks: